David Belair
Principal Scientist - Research Abbvie
Seminars
Tuesday 4th November 2025
Assessing PK/PD Modeling Strategies for Degrader Conjugates to Enable Clinical Translation
2:00 pm
- Exploring degrader modality and opportunities for degrading undruggable targets
- Explaining how ADCs leverage target-mediated cellular uptake to improve therapeutic index and ADME advantages of degrader ADCs
- Discussing PK/PD modeling strategies for degraders and degrader ADCs that enable clinical translation
